Logo image of AMS

AMERICAN SHARED HOSPITAL SER (AMS) Stock Fundamental Analysis

NYSEARCA:AMS - NYSE Arca - US0295951059 - Common Stock - Currency: USD

2.75  -0.07 (-2.48%)

Fundamental Rating

4

Taking everything into account, AMS scores 4 out of 10 in our fundamental rating. AMS was compared to 102 industry peers in the Health Care Providers & Services industry. AMS has only an average score on both its financial health and profitability. AMS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

AMS had negative earnings in the past year.
AMS had a positive operating cash flow in the past year.
AMS had positive earnings in 4 of the past 5 years.
In the past 5 years AMS always reported a positive cash flow from operatings.
AMS Yearly Net Income VS EBIT VS OCF VS FCFAMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

The Return On Assets of AMS (3.63%) is better than 68.57% of its industry peers.
AMS has a Return On Equity of 8.68%. This is in the better half of the industry: AMS outperforms 72.38% of its industry peers.
AMS has a Return On Invested Capital (2.82%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for AMS is below the industry average of 9.13%.
Industry RankSector Rank
ROA 3.63%
ROE 8.68%
ROIC 2.82%
ROA(3y)2.64%
ROA(5y)-1.57%
ROE(3y)5.84%
ROE(5y)-3.63%
ROIC(3y)4.67%
ROIC(5y)N/A
AMS Yearly ROA, ROE, ROICAMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

With an excellent Profit Margin value of 7.71%, AMS belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
AMS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 6.27%, AMS is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
In the last couple of years the Operating Margin of AMS has declined.
Looking at the Gross Margin, with a value of 32.41%, AMS is in line with its industry, outperforming 59.05% of the companies in the same industry.
In the last couple of years the Gross Margin of AMS has remained more or less at the same level.
Industry RankSector Rank
OM 6.27%
PM (TTM) 7.71%
GM 32.41%
OM growth 3Y-20.48%
OM growth 5Y-14.68%
PM growth 3Y92.72%
PM growth 5Y19.22%
GM growth 3Y-5.31%
GM growth 5Y-0.7%
AMS Yearly Profit, Operating, Gross MarginsAMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

AMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AMS has more shares outstanding
Compared to 5 years ago, AMS has more shares outstanding
Compared to 1 year ago, AMS has a worse debt to assets ratio.
AMS Yearly Shares OutstandingAMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
AMS Yearly Total Debt VS Total AssetsAMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

AMS has an Altman-Z score of 1.32. This is a bad value and indicates that AMS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.32, AMS is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.69 indicates that AMS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.69, AMS is in line with its industry, outperforming 49.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACC0.33
WACC8.54%
AMS Yearly LT Debt VS Equity VS FCFAMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

AMS has a Current Ratio of 2.52. This indicates that AMS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.52, AMS belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
AMS has a Quick Ratio of 2.52. This indicates that AMS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.52, AMS belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 2.52
AMS Yearly Current Assets VS Current LiabilitesAMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 254.13% over the past year.
AMS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.28% yearly.
Looking at the last year, AMS shows a very strong growth in Revenue. The Revenue has grown by 32.88%.
The Revenue has been growing slightly by 6.58% on average over the past years.
EPS 1Y (TTM)254.13%
EPS 3Y121.52%
EPS 5Y24.28%
EPS Q2Q%-433.33%
Revenue 1Y (TTM)32.88%
Revenue growth 3Y17.14%
Revenue growth 5Y6.58%
Sales Q2Q%59.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y168.86%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year28.62%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMS Yearly Revenue VS EstimatesAMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
AMS Yearly EPS VS EstimatesAMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 0.2 -0.2 0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMS. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 18.15 indicates a rather expensive valuation of AMS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMS indicates a somewhat cheap valuation: AMS is cheaper than 69.52% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of AMS to the average of the S&P500 Index (21.32), we can say AMS is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 18.15
AMS Price Earnings VS Forward Price EarningsAMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

AMS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMS is cheaper than 98.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.38
AMS Per share dataAMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AMS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN SHARED HOSPITAL SER

NYSEARCA:AMS (4/25/2025, 8:04:00 PM)

2.75

-0.07 (-2.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-04 2025-04-04/bmo
Earnings (Next)05-08 2025-05-08
Inst Owners16.56%
Inst Owner Change-85.95%
Ins Owners30.23%
Ins Owner Change2.11%
Market Cap17.74M
Analysts80
Price Target4.94 (79.64%)
Short Float %1.28%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1108.66%
Min EPS beat(2)-2080.2%
Max EPS beat(2)-137.13%
EPS beat(4)0
Avg EPS beat(4)-591.37%
Min EPS beat(4)-2080.2%
Max EPS beat(4)-33.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)4.32%
Min Revenue beat(2)-7.97%
Max Revenue beat(2)16.61%
Revenue beat(4)3
Avg Revenue beat(4)6.33%
Min Revenue beat(4)-7.97%
Max Revenue beat(4)16.61%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.21%
PT rev (3m)7.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-50%
EPS NY rev (3m)-62.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)9.26%
Revenue NY rev (3m)9.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.15
P/S 0.63
P/FCF N/A
P/OCF 106.21
P/B 0.7
P/tB 0.74
EV/EBITDA 3.38
EPS(TTM)-0.22
EYN/A
EPS(NY)0.15
Fwd EY5.51%
FCF(TTM)-1.2
FCFYN/A
OCF(TTM)0.03
OCFY0.94%
SpS4.39
BVpS3.9
TBVpS3.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.63%
ROE 8.68%
ROCE 3.57%
ROIC 2.82%
ROICexc 3.62%
ROICexgc 3.75%
OM 6.27%
PM (TTM) 7.71%
GM 32.41%
FCFM N/A
ROA(3y)2.64%
ROA(5y)-1.57%
ROE(3y)5.84%
ROE(5y)-3.63%
ROIC(3y)4.67%
ROIC(5y)N/A
ROICexc(3y)6.77%
ROICexc(5y)N/A
ROICexgc(3y)7.11%
ROICexgc(5y)N/A
ROCE(3y)6.05%
ROCE(5y)N/A
ROICexcg growth 3Y-13.43%
ROICexcg growth 5Y-5.81%
ROICexc growth 3Y-13.18%
ROICexc growth 5Y-6.48%
OM growth 3Y-20.48%
OM growth 5Y-14.68%
PM growth 3Y92.72%
PM growth 5Y19.22%
GM growth 3Y-5.31%
GM growth 5Y-0.7%
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA 2.18
Cap/Depr 128.57%
Cap/Sales 28.01%
Interest Coverage 1.27
Cash Conversion 2.1%
Profit Quality N/A
Current Ratio 2.52
Quick Ratio 2.52
Altman-Z 1.32
F-Score5
WACC8.54%
ROIC/WACC0.33
Cap/Depr(3y)86.06%
Cap/Depr(5y)59.68%
Cap/Sales(3y)19.8%
Cap/Sales(5y)14.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)254.13%
EPS 3Y121.52%
EPS 5Y24.28%
EPS Q2Q%-433.33%
EPS Next Y168.86%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.88%
Revenue growth 3Y17.14%
Revenue growth 5Y6.58%
Sales Q2Q%59.16%
Revenue Next Year28.62%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.56%
EBIT growth 3Y-6.85%
EBIT growth 5Y-9.07%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1300.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-97.08%
OCF growth 3Y-70.14%
OCF growth 5Y-53.93%